Discover open access scientific publications

A Single Course of Anti-Cd3 Monoclonal Antibody hOKT3 1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years After Onset of Type 1 Diabetes